
Celiac disease, affecting 1% to 3% of people worldwide, is an autoimmune condition triggered by gluten, linked to genetic and unidentified environmental factors.
Read More
A study published in Frontiers in Microbiology examined gut bacteria in children diagnosed with celiac disease in Canterbury, New Zealand, a region with a high prevalence of the condition. Researchers analyzed the gut microbiome of 11 children newly diagnosed with celiac disease before treatment and compared it to that of 10 healthy children. Six months after the children with celiac disease adopted a gluten-free diet, they were retested to assess changes in their gut bacteria.
The findings indicated that celiac disease consistently altered the composition of gut bacteria. Notably, there was a significant increase in Bacteroides ovatus among the affected children, accompanied by a rise in related metabolites, including markers associated with butyrate fermentation and stress. These markers were elevated prior to treatment but decreased following the adoption of the gluten-free diet, although they did not return to normal levels.
Additionally, the gluten-free diet led to an increase in the bacterium Bilophila wadsworthia. Despite the inability to fully distinguish between the gut bacteria of children with celiac disease and those of healthy children based on the collected data, the observed bacterial and chemical changes followed a consistent pattern, hinting at a potential relationship that may inform disease progression and recovery.
Though this is a preliminary study, its findings may pave the way for future diagnostic methods and monitoring of treatment efficacy. Further research could also identify new therapeutic targets for celiac disease.
The study is led by Peter J. Prendergast and collaborators, and was published on July 31, 2026.